BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36738485)

  • 21. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
    Eaglehouse YL; Darcy KM; Tian C; Casablanca Y; Shriver CD; Zhu K
    Obstet Gynecol; 2021 Apr; 137(4):629-640. PubMed ID: 33706355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Potential years of life lost to cancer in Mato Grosso, stratified by sex: 2000 to 2019.
    Galvão SM; Atanaka M; Sousa NFDS; Galvão ND
    Rev Bras Epidemiol; 2022; 25(Supl 1):e220009. PubMed ID: 35766766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and ethnic disparities in lifetime risk of corpus uterine cancer: a comparative study of Puerto Rico and the United States SEER population.
    Ortiz AP; Otero Y; Svensson K; García-Rodríguez O; Garced S; Santiago E; Umpierre S; Figueroa N; Ortiz-Ortiz KJ
    Ethn Dis; 2012; 22(1):90-5. PubMed ID: 22774315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in Place of Death Among Patients With Gynecologic Cancer in the United States.
    Hicks-Courant K; Melamed A; Worley MJ; Kim YB; Schorge JO; Rauh-Hain JA
    Obstet Gynecol; 2018 Jun; 131(6):1111-1120. PubMed ID: 29742673
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Disparities in gynecologic cancer incidence, treatment, and survival: a narrative review of outcomes among black and white women in the United States.
    Towner M; Kim JJ; Simon MA; Matei D; Roque D
    Int J Gynecol Cancer; 2022 Jul; 32(7):931-938. PubMed ID: 35523443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Racial/ethnic disparities in breast and gynecologic cancer treatment and outcomes.
    Tammemagi CM
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):31-6. PubMed ID: 17218849
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gynecologic malignancies of the elderly.
    Weintraub NT; Freedman ML
    Clin Geriatr Med; 1987 Nov; 3(4):669-94. PubMed ID: 3315162
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Trends of premature mortality in Swietokrzyskie Province (Poland), years 2002-2010.
    Gózdz S; Krzyzak M; Maślach D; Wróbel M; Bielska-Lasota M
    Rocz Panstw Zakl Hig; 2013; 64(3):205-10. PubMed ID: 24325087
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Scope and Epidemiology of Gynecologic Cancers: An Overview.
    Ledford LRC; Lockwood S
    Semin Oncol Nurs; 2019 Apr; 35(2):147-150. PubMed ID: 30902519
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Health Care Disparities in Hysterectomy for Gynecologic Cancers: Data From the 2012 National Inpatient Sample.
    Esselen KM; Vitonis A; Einarsson J; Muto MG; Cohen S
    Obstet Gynecol; 2015 Nov; 126(5):1029-1039. PubMed ID: 26444112
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Premature Years of Life Lost Due to Cancer in the United States in 2017.
    Song M; Hildesheim A; Shiels MS
    Cancer Epidemiol Biomarkers Prev; 2020 Dec; 29(12):2591-2598. PubMed ID: 33187970
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serum antibodies to the 27-kd heat shock protein in women with gynecologic cancers.
    Korneeva I; Bongiovanni AM; Girotra M; Caputo TA; Witkin SS
    Am J Obstet Gynecol; 2000 Jul; 183(1):18-21. PubMed ID: 10920302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial/Ethnic Disparities in Lost Earnings From Cancer Deaths in the United States.
    Zhao J; Miller KD; Islami F; Zheng Z; Han X; Ma J; Jemal A; Yabroff KR
    JNCI Cancer Spectr; 2020 Oct; 4(5):pkaa038. PubMed ID: 33134823
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidences and risk factors of metachronous vulvar, vaginal, and anal cancers after cervical cancer diagnosis.
    Matsuo K; Blake EA; Machida H; Mandelbaum RS; Roman LD; Wright JD
    Gynecol Oncol; 2018 Sep; 150(3):501-508. PubMed ID: 30054103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    Bassett MT; Chen JT; Krieger N
    PLoS Med; 2020 Oct; 17(10):e1003402. PubMed ID: 33079941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. OPTIMUM MANAGEMENT OF GYNECOLOGIC CANCER.
    GRAHAM JB
    N Y State J Med; 1964 Jun; 64():1306-7. PubMed ID: 14147175
    [No Abstract]   [Full Text] [Related]  

  • 37. Disparities in Gynecologic Cancers.
    Lee NK; Tiro JA; Odunsi K
    Cancer J; 2023 Nov-Dec 01; 29(6):343-353. PubMed ID: 37963369
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ACCURACY OF CYTOLOGIC DIAGNOSIS IN THE TREATED CANCER.
    GRAHAM RM
    Acta Cytol; 1964; 8():3-10. PubMed ID: 14110624
    [No Abstract]   [Full Text] [Related]  

  • 39. Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.
    Yun BS; Park EH; Ha J; Lee JY; Lee KH; Lee TS; Lee KJ; Kim YJ; Jung KW; Roh JW
    Obstet Gynecol Sci; 2023 Nov; 66(6):545-561. PubMed ID: 37953552
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Survival Disparities by Hospital Volume Among American Women With Gynecologic Cancers.
    Seagle BL; Strohl AE; Dandapani M; Nieves-Neira W; Shahabi S
    JCO Clin Cancer Inform; 2017 Nov; 1():1-15. PubMed ID: 30657373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.